Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
Giselle S. Escouto, Gabriela Z. Port, Cristiane Valle Tovo, et al.
Journal of Nutrition (2023) Vol. 153, Iss. 7, pp. 1984-1993
Open Access | Times Cited: 22

Showing 22 citing articles:

Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
Youwen Pan, Yafang Yang, Jiale Wu, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
Yuezhi Zhu, Jen Kit Tan, Jia Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 329-329
Open Access | Times Cited: 8
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yijia Song, Sutong Liu, Lihui Zhang, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial
Naama Reshef, Uri Gophna, Leah Reshef, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1571-1571
Open Access | Times Cited: 6
Gut microbiota in MAFLD: therapeutic and diagnostic implications
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 5
Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
Xiaoxia Qiu, Sheng‐Li Cheng, Yan‐Hui Liu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 833-842
Open Access | Times Cited: 4
Overcoming Immunotherapy Resistance in Colorectal Cancer through Nano-Selenium Probiotic Complexes and IL-32 Modulation
Shiquan Li, Tao Liu, Chenyao Li, et al.
Biomaterials (2025) Vol. 320, pp. 123233-123233
Closed Access
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
Farah Abdelhameed, A.I. Mustafa, Chris Kite, et al.
Livers (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
Potential Probiotics for the Therapy of Metabolic Dysfunction-Associated Steatotic Liver Disease
Xiayun Li, Liyan Yu, Zong‐Gen Peng, et al.
IntechOpen eBooks (2025)
Closed Access
Poultry Nutrition: Achievement, Challenge and Strategy
Kexin Cao, Zhang‐Chao Deng, Shijun Li, et al.
Journal of Nutrition (2024) Vol. 154, Iss. 12, pp. 3554-3565
Closed Access | Times Cited: 3
Gut microbiota and metabolite interface-mediated hepatic inflammation
Ming Yang, Katina Massad, Eric T. Kimchi, et al.
Immunometabolism (2024) Vol. 6, Iss. 1, pp. e00037-e00037
Open Access | Times Cited: 2
Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis
Yafang Yang, Ligang Yang, Jiale Wu, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 6, pp. 1224-1239
Closed Access | Times Cited: 2
Exploring the Correlation Between Vitamin D Levels and Serological Markers in Liver Diseases: Insights from a Cross-Sectional Study
Adina Ioana Mihele, Sergiu Cristian Hocopan, Sergiu Dorin Matei, et al.
In Vivo (2024) Vol. 38, Iss. 5, pp. 2271-2283
Open Access | Times Cited: 1
Gut microbiota–NLRP3 inflammasome crosstalk in metabolic dysfunction-associated steatotic liver disease
Tingting Yu, Lei Luo, Juan Xue, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102458-102458
Open Access | Times Cited: 1
The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt
Alaa Ahmed Abd El Hamid, Azza Emam Mohamed, Manal sabry Mohamed, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Role of the Gut Microbiome in Metabolic dysfunction-Associated Steatotic Liver Disease
Salim Maher, Jayashi Rajapakse, Emad El‐Omar, et al.
Seminars in Liver Disease (2024)
Closed Access | Times Cited: 1
Influence of gender, age, and body mass index on the gut microbiota of individuals from South China
Shenghui Li, Shao Fan, Yufang Ma, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Role of Plantaricin Produced by Lactiplantibacillus Plantarum in Alleviating Third-Generation Antibiotic Toxicity in a Zebrafish (Danio Rerio) Model
Meera N. Subramanyam, Naveen Thanjavur, Buddolla Viswanath, et al.
(2024)
Closed Access
The Influence of Liver Cirrhosis, Additional Probiotics, and Alcohol Consumption on Hepatic Fibrosis and the Gut Microbiota Deserves Attention
Fei Du, Linghui Tao
Journal of Nutrition (2024) Vol. 154, Iss. 6, pp. 1959-1959
Closed Access
Effects of Synbiotic Administration on Gut Microbiome and Fecal Bile Acids in Dogs with Chronic Hepatobiliary Disease: A Randomized Case–Control Study
Verena Habermaass, C. Biolatti, Francesco Bartoli, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 8, pp. 364-364
Open Access
The role of probiotics in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD): new insights based on meta-analysis and subgroup analysis
M. Xiao, Yang Cao, Linlin Wang, et al.
Food Bioscience (2024) Vol. 62, pp. 105454-105454
Closed Access
Reply to F Du and L Tao
Caroline Buss, André Marette, Giselle S. Escouto, et al.
Journal of Nutrition (2024) Vol. 154, Iss. 6, pp. 1960-1960
Closed Access
Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in mice
Qiong Wu, Fangsi Zhu, Yu Yao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top